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Abstract
Background: In patients with left ventricular non-compaction (LVNC), implantation of a left ventricular assist device
(LVAD) may be performed as a bridge to transplantation. In this respect, the particular characteristics of the left
ventricular myocardium may represent a challenge.
Case presentation: We report a patient with LVNC who required urgent heart transplantation for inflow cannula
obstruction nine months after receiving a LVAD. LVAD parameters, echocardiography and examination of the
explanted heart suggested changes of left ventricular configuration brought about by LVAD support as the most
likely cause of inflow cannula obstruction.
Conclusions: We conclude that changes experienced by non-compacted myocardium during LVAD support may
give rise to inflow cannula obstruction and flow reduction. Presence of LVNC mandates tight surveillance for
changes in LV configuration and LVAD flow characteristics and may justify urgent transplantation listing status.
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Background
Left ventricular non-compaction (LVNC) is attributed to
arrest of normal embryogenesis of the endocardium and
myocardium and results in a two-layered structure of
the left ventricle (LV). In addition to a compacted outer
layer, the LV comprises a spongy non-compacted inner
layer with heavy trabeculation and deep intertrabecular
recesses [1, 2]. Though its incidence and prevalence
are still uncertain, LVNC was recently suggested to
represent the third most commonly diagnosed cardio-
myopathy [3]. The major clinical findings in LVNC
are heart failure, arrhythmias and thromboembolic
events [1, 2]. In patients with end-stage heart failure,
LVAD implantation may be performed as a bridge to
transplantation [4–7].
While previous authors focused on thromboembolic
events [5, 7] and arrhythmia [7] associated with LVAD
support in LVNC, the changes non-compacted left
ventricular myocardium may experience during LVAD
support also merit investigation. Our case sheds light on
LVAD support in LVNC from a different angle and raises
questions with regard to the duration of support being
likely to be limited by support-induced changes of
non-compacted myocardium, LV configuration and LVAD
flow behaviour.
Case report
A 35-year-old male with LVNC underwent off-pump
LVAD implantation (HVAD, HeartWare Inc.) through a
minimally invasive access. Presence of trabeculation
obstructing the inflow cannula was excluded by digital
exploration before introduction of the LVAD. Correct
inflow cannula position and absence of obstruction were
additionally verified by transesophageal echocardiog-
raphy and evaluation of LVAD flow behaviour before
closure. After an uneventful hospital stay and subse-
quent exercise tolerance and quality of life improvement,
the patient presented with low flow alarms and had his
LVAD speed re-adjusted several times. After nine
months, he was readmitted for perilously low flows that
intermittently dropped to 500 ml/min. This was inter-
preted as the consequence of an excess of outdoor
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activity and volume depletion, and when LVAD flows in-
creased satisfactorily after administration of fluids, the
patient was discharged the next day. Subsequently,
LVAD flows kept dropping intermittently over a few
weeks, and finally the patient ceased to respond to
administration of fluids and developed signs of heart
failure. He was re-admitted, and his waiting list status
was set to high urgency.
After four weeks of medical treatment, he was put
on extracorporeal life support (ECLS). By that time,
changes in LV configuration had come to be sus-
pected as the cause of LVAD dysfunction. Echocardi-
ography showed the LV cavity smaller and the LV
walls thicker than before LVAD implantation, with
heavy trabeculation within the LV and a solid struc-
ture appearing to cross in front of the inflow cannula
opening (Fig. 1).
After 45 days on ECLS, the patient underwent heart
transplantation. Macroscopic examination of the
explanted heart confirmed the findings on echocardi-
ography. The LV cavity was narrow and partially
obliterated by dense tissue. In particular, there was a
rigid trabecular structure stretching across the LV in
front of and appearing to have overgrown the LVAD
inflow cannula. The left ventricular wall showed
massive thickening to nearly 30 mm, with the myo-
cardium spongy and interspersed with yellowish fatty
deposits (Fig. 2).
Discussion
LVNC was found to lead to severe heart failure in a con-
siderable share of those diagnosed with the condition,
with 47 % [1] and 60 % [8] reported to have either died
or undergone transplantation within a mean follow-up
period of 44 ± 40 months and within 6 years of diagno-
sis, respectively. Nevertheless, reports on VAD implant-
ation in patients with LVNC are infrequent, especially
when those featuring pediatric patients supported with
pulsatile systems [9–11] are left aside (Table 1).
Ninios et al. [5] reported off-pump implantation of a
Jarvik 2000 LV via a left posterolateral thoracotomy,
while Maile et al. [4] described a case of implantation of
a DeBakey LVAD in a patient with LVNC. 5 patients
reported by Uribarri et al. [7] underwent on-pump
HeartMate II implantation through a full sternotomy
or on-pump HVAD implantation through an upper
hemisternotomy and left-sided anterolateral thoracot-
omy. In this series, thrombosis was the main issue, with
arrhythmia investigated as a second outcome parameter
[7]. In the case reported by Ninios et al., the focus was
also on the association between LVNC and pump
thrombosis [5]. The patient reported by Maile et al. [4]
underwent transplantation after 2.5 months of unevent-
ful LVAD support, and Ivan et al. [6] reported two cases
that took a fatal course after biventricular assist devices
were implanted as a last remedy. In none of the cases
published to date, however, mention was made of
Fig. 1 Transthoracic echocardiography 9 months after LVAD implantation: a short axis view showing trabeculated left ventricular myocardium;
b tilted short axis view showing a solid structure stretching across the LV in front of the LVAD inflow cannula (arrow), c parasternal long axis view
showing thick, spongy LV myocardium and narrow LV cavity, d inverted tilted four chamber view showing thickened LV myocardium with small
LV cavity appearing divided by a solid structure
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complications resulting from the particular structure of
the left ventricular myocardium in patients with LVNC
even though some of the patients were on LVAD sup-
port for considerably longer periods than our patient
[5, 7] and Uribarri et al. [7] explicitly reported the apex
to be the region that was most frequently affected by
non-compaction in their patients.
The latter finding is in keeping with previous literature
reporting the typical features of LVNC to be located pre-
dominantly in the apical and mid-ventricular segments
of the LV [1], which is relevant in that trabecular struc-
tures within a nearly obliterated apex may result in
obstruction of the inflow cannula. In this respect, the
implantation method may be of relevance, because on-
pump implantation allows more thorough inspection
and palpation of the left ventricle in order to exclude
presence of or remove apical trabecular structures
that may result in obstruction of the inflow cannula.
In our case, off-pump HVAD implantation was un-
complicated, obstruction of the inflow cannula by apical
trabecular structures was excluded by digital palpation
as well as by transesophageal echocardiography, and
unhindered blood flow into the inflow cannula was
reflected by normal LVAD flow characteristics. In hind-
sight, however, on-pump implantation would have
allowed not only inspection of the left ventricular apex,
but also excision of excess tissue. On the other hand, the
fact that first signs of inflow cannula obstruction oc-
curred after several months of uneventful support and
absence, in earlier echocardiographic examinations, of
the heavy apical and mid-ventricular trabecular masses
seen on echocardiography after readmission for LVAD
dysfunction suggest that at least part of the changes that
finally resulted in inflow cannula obstruction must have
occurred over time.
While decompression of the LV is a normal and desir-
able consequence of LV unloading, the extreme degree
of narrowing of the LV cavity we saw in the explanted
heart as well as the heavy mass of rigid trabeculated tis-
sue around the inflow cannula represent unusual find-
ings. They are most likely explained by LV configuration
and the geometry and density of pre-existing trabecu-
lated tissue having changed in response to the
hemodynamic changes that were brought about by
LVAD support.
Conclusion
We conclude that LVNC may turn out to be a cause of
inflow cannula obstruction and flow reduction even
where LVAD function was normal upon implantation.
On-pump implantation may be advisable with a view to
inspecting the inflow opening and excising excess
tissue, thus preventing subsequent catastrophic inflow
obstruction. LVNC requires a high index of suspicion
and mandates tight surveillance of LVAD flow charac-
teristics and LV configuration. If LVNC actually turns
out to be a limiting factor in LVAD therapy, it may
justify more liberal access to high urgency listing for
patients afflicted with this particular condition.
Fig. 2 Heart explanted after nine months of LVAD support: a HVAD inflow cannula protruding into massively enlarged heart, b trabeculated
tissue surrounding the inflow cannula, c dense stretch of trabeculated tissue obstructing the opening of the inflow cannula within partially
obliterated apex, d thick, spongy myocardium interspersed with fatty deposits
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Table 1 Outcomes of LVAD implantation in patients with left ventricular non-compaction
No. Patients Device Duration of support Complications Outcome
Maile et al., 2004 [4] 1 Male, 51 years DeBakey MicroMed LVAD 2.5 months None Successfully bridged to transplantation
Ivan et al., 2005 [6] 2 Male, 21 years Jarvik biventricular
assist device
Not indicated Not indicated Death before transplantation
Male, 37 years Thoratec RVAD and
HeartMate LVAD
Not indicated Not indicated Death after transplantation
Nathan et al., 2010 [9] 1 Male, 14 years Abiomed, biventricular
assist device
5 days None Successfully bridged to transplantation
Ninios et al., 2010 [5] 1 Male, 28 years Jarvik 2000 LV 3 years Recurrent thrombosis with
successful intravenous lysis
Patient on LVAD support at the date of
publication
Hanke et al., 2012 [10] 1 Male, 12 months Berlin Heart, Excor,
biventricular assist device
24 days Pulmonary haemorrhage




Successfully bridged to transplantation
Siehr et al., 2013 [11] 1 Male, 6 weeks Berlin Heart, Excor, LVAD 56 days Embolic cerebrovascular
accident, 2 pump exchanges
due to clot formation
Successfully bridged to transplantation
Uribarri et al., 2015 [7] 5 4 males
(23, 25, 43,54 years)
1 female (24 years)
3 HVAD
2 HeartMate II
Mean follow up period
86.5 weeks, range
40–194 weeks
4 cases of pump thrombosis
in 3 of 5 patients
2 deaths, 3 patients on LVAD support












ECLS, extracorporeal life support; HVAD, left ventricular assist device supplied
by HeartWare Inc; LV, left ventricle, left ventricular; LVAD, left ventricular assist
device; LVNC, left ventricular non compaction; VAD, ventricular assist device
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